HLA-A*03 may confer protection against long COVID through an enhanced immune response
HLA-A*03 may play a protective role against Long COVID, potentially through enhanced immune responses involving CD8<sup>+</sup> T cells and NK cells. Further research in larger, diverse cohorts is needed to validate these findings and to refine personalized medicine strategies for managing COVID-19 sequelae.
Authors
- Diana Ceballos‐Francisco (ORCID: https://orcid.org/0000-0001-5205-5757)
- María José Alcaraz García (ORCID: https://orcid.org/0000-0002-1057-0299)
- Inmaculada Ruiz-Lorente (ORCID: https://orcid.org/0009-0009-2433-8755)
- Eduardo Pons-Fuster (ORCID: https://orcid.org/0000-0001-9595-5982)
- Marta Moreno (ORCID: https://orcid.org/0000-0002-9091-5612)
- José María Pérez Gómez
- Elisa Ma Sahún García
- Alfredo Minguela (ORCID: https://orcid.org/0000-0003-2472-5893)
- Enrique Bernal (ORCID: https://orcid.org/0000-0002-4041-0579)
- María V. Martínez‐Sánchez
- Ana Peláez
- Ángeles Muñoz
- Cristina Tomás
- Rodrigo Martínez-Rodríguez
- Lourdes Gimeno-Arias
Institutions
- Hospital General Universitario Morales Meseguer (ES)
- Hospital Rafael Méndez (ES)
- Hospital Reina Sofía de Murcia (ES)
- Instituto Murciano de Investigación Biosanitaria (ES)
- Universidad de Murcia (ES)
Publication Details
- Journal
- Infectious Diseases Now
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1016/j.idnow.2025.105057
- Citations
- 1
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 1.39